Nasal septal hematoma

 

Clinical Pathology: Nasal Septal Hematoma

High-Yield Revision Notes for NEET PG / NEXT

A Nasal Septal Hematoma is a critical emergency characterized by the collection of blood between the cartilaginous or bony nasal septum and its overlying mucoperichondrium or mucoperiosteum. Prompt diagnosis and surgical drainage are essential to prevent irreversible avascular necrosis of the septal framework.

1. Pathomechanics & Pathophysiology

Understanding the anatomy of the septal matrix reveals why this condition is a surgical emergency:

  • Primary Etiology: Nasal trauma (nasal bone fractures, sports injuries, or accidental falls) and iatrogenic causes (secondary to septoplasty or sub-mucous resection).
  • Vascular Mechanism: Trauma tears the submucosal vessels of the septum. Blood accumulates under high pressure, stripping the perichondrium away from the cartilage.
  • The Ischemic Loop: The quadrilateral septal cartilage possesses no intrinsic blood supply. It depends entirely on the diffusion of nutrients from the capillaries of the overlying mucoperichondrium. The accumulating hematoma creates a physical barrier that cuts off this diffusion.
  • The Destruction Timeline: Unrelieved pressure leads to avascular ischemic necrosis of the septal cartilage within 48 to 72 hours.

2. Clinical Manifestations & Physical Diagnosis

The diagnosis is primarily clinical. Delaying treatment while waiting for radiological imaging is a major management error.

  • Classic Symptoms: Severe, progressive **nasal obstruction** (typically bilateral as the blood easily tracks around the posterior border of the cartilage or through a fracture line to the opposite side), localized dull pain, headache, and minor epistaxis.
  • Anterior Rhinoscopy Signs: Visual inspection reveals a smooth, reddish-purple, **bilateral boggy swelling** protruding from the septum, which completely occludes the nasal cavities.
  • The Palpation Test: Probing or gently touching the mass with a cotton-tipped applicator reveals a soft, **fluctuant** mass (unlike a deviated nasal septum, which feels hard, rigid, and bony).

3. Critical Complications & Board Targets

Complication Pathological Sequence & Clinical Consequence
Septal Abscess Stagnant blood provides an ideal culture medium. The hematoma frequently undergoes secondary bacterial contamination (mostly by Staphylococcus aureus, Streptococcus pneumoniae, or Haemophilus influenzae), transforming into an abscess within days. This is marked by a sudden escalation in pain, high fever, and extreme nasal tenderness.
Saddle Nose Deformity Extensive ischemic cartilage necrosis causes the structural breakdown of the upper half of the nose. Once the dorsal support grid collapses, it yields a permanent cosmetic **sinking of the nasal bridge** (Saddle Nose).
Permanent Septal Perforation Sloughing of both the necrotic cartilage and the apposing mucosal layers creates a permanent, non-healing structural defect connecting the left and right nasal chambers, causing turbulence and whistling during inspiration.
Intracranial Seeding Uncontrolled septal abscesses can track superiorly along the ethmoidal venous lines or directly through a fractured cribriform plate, provoking **meningitis**, brain abscess, or retrograde **cavernous sinus thrombosis**.

4. Management Protocol

The standard treatment is immediate surgical evacuation:

  1. Incision: Under local or general anesthesia, a wide vertical or L-shaped incision is made over the most fluctuant area of the swelling.
  2. Evacuation: The clotted blood, serum, or purulent contents are completely suctioned out. Any loose, free-floating fragments of necrotic cartilage are debrided.
  3. Prevention of Re-accumulation: To ensure the mucosal flaps readhere to the cartilage grid and close the dead space, **bilateral anterior nasal packing** is placed securely for 48 hours. Alternatively, silicone splints or mattress transfixion sutures can be used.
  4. Antibiotic Coverage: Empiric systemic antistaphylococcal antibiotic coverage must be initiated immediately to prevent the development of a toxic shock syndrome or intracranial migration.